Pathway Mechanism of Potential Genomic Markers of Dipeptidyl Peptidase-4 Inhibitor Treatment Response in Type 2 Diabetes

被引:0
|
作者
Jamaluddin, J. L. [1 ]
Huri, H. Z. [1 ]
Vethakkan, S. R. [2 ]
Mustafa, N. [2 ]
Ahmad, W. A. W. [2 ]
机构
[1] Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur 50603, Malaysia
[2] Univ Malaya, Med Ctr, Clin Invest Ctr, Kuala Lumpur 59100, Malaysia
关键词
D O I
暂无
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
P005
引用
收藏
页码:9 / 9
页数:1
相关论文
共 50 条
  • [41] Cost Effectiveness of Dipeptidyl Peptidase-4 Inhibitors for Type 2 Diabetes
    Jinsong Geng
    Hao Yu
    Yiwei Mao
    Peng Zhang
    Yingyao Chen
    PharmacoEconomics, 2015, 33 : 581 - 597
  • [42] Safety of dipeptidyl peptidase-4 inhibitors for treating type 2 diabetes
    Scheen, Andre J.
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (04) : 505 - 524
  • [43] Cost Effectiveness of Dipeptidyl Peptidase-4 Inhibitors for Type 2 Diabetes
    Geng, Jinsong
    Yu, Hao
    Mao, Yiwei
    Zhang, Peng
    Chen, Yingyao
    PHARMACOECONOMICS, 2015, 33 (06) : 581 - 597
  • [44] DIPEPTIDYL PEPTIDASE-4 AND RISK OF PSORIASIS IN PATIENTS WITH TYPE 2 DIABETES
    Chen, W. S.
    Chang, Y. S.
    Tsai, C. Y.
    Chang, C. C.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1246 - 1247
  • [45] Dipeptidyl peptidase-4 inhibitor for steroid-induced diabetes
    Yanai, Hidekatsu
    Masui, Yoshinori
    Yoshikawa, Reo
    Kunimatsu, Junwa
    Kaneko, Hiroshi
    WORLD JOURNAL OF DIABETES, 2010, 1 (03): : 99 - 100
  • [47] A dipeptidyl peptidase-4 inhibitor reverses diabetes in NOD mice
    Suarez-Pinzon, Wilma L.
    Rabinovitch, Alex
    DIABETES, 2007, 56 : A419 - A419
  • [48] Emerging dipeptidyl peptidase-4 inhibitors for the treatment of diabetes
    Ahren, Bo
    EXPERT OPINION ON EMERGING DRUGS, 2008, 13 (04) : 593 - 607
  • [50] Mechanisms of Cardiovascular Injury in Type 2 Diabetes and Potential Effects of Dipeptidyl Peptidase-4 Inhibition
    Dokken, Betsy
    JOURNAL OF CARDIOVASCULAR NURSING, 2016, 31 (03) : 274 - 283